Weei Lo1, Martha O'Donnell2, Daniel Tancredi1, Myra Orgain1, Nicole Glaser1. 1. Department of Pediatrics, University of California Davis, School of Medicine, Sacramento, CA, USA. 2. Departments of Physiology and Membrane Biology, University of California Davis, School of Medicine, Sacramento, CA, USA.
Abstract
BACKGROUND: Type 1 diabetes may be associated with structural and functional alterations in the brain. The role of diabetic ketoacidosis (DKA) in causing these alterations has not been well explored. METHODS: We used immunohistochemical staining to investigate cellular alterations in brain specimens from juvenile rats with DKA before, during, and after treatment with insulin and saline, and compared these to samples from diabetic rats and normal controls. RESULTS: Glial fibrillary acidic protein (GFAP) staining intensity was increased in the hippocampus during DKA and increased further during insulin/saline treatment. Twenty-four and 72 h after treatment, hippocampal GFAP intensity declined but remained above control levels. There were no significant changes in GFAP intensity in the cortex or striatum. OX42 staining intensity was increased during untreated DKA and increased further during insulin/saline treatment in the hippocampus and cortex. NeuN staining intensity was decreased after DKA treatment in the striatum but not in other regions. CONCLUSIONS: DKA causes inflammatory changes in the brain including reactive gliosis and activation of microglia. These findings are present during untreated DKA, but intensify during insulin/saline treatment. The hippocampus was disproportionately affected, consistent with previous studies showing deficits in hippocampal functions in rats after DKA recovery and decreased memory capacity in children with a history of DKA.
BACKGROUND: Type 1 diabetes may be associated with structural and functional alterations in the brain. The role of diabetic ketoacidosis (DKA) in causing these alterations has not been well explored. METHODS: We used immunohistochemical staining to investigate cellular alterations in brain specimens from juvenile rats with DKA before, during, and after treatment with insulin and saline, and compared these to samples from diabeticrats and normal controls. RESULTS:Glial fibrillary acidic protein (GFAP) staining intensity was increased in the hippocampus during DKA and increased further during insulin/saline treatment. Twenty-four and 72 h after treatment, hippocampal GFAP intensity declined but remained above control levels. There were no significant changes in GFAP intensity in the cortex or striatum. OX42 staining intensity was increased during untreated DKA and increased further during insulin/saline treatment in the hippocampus and cortex. NeuN staining intensity was decreased after DKA treatment in the striatum but not in other regions. CONCLUSIONS: DKA causes inflammatory changes in the brain including reactive gliosis and activation of microglia. These findings are present during untreated DKA, but intensify during insulin/saline treatment. The hippocampus was disproportionately affected, consistent with previous studies showing deficits in hippocampal functions in rats after DKA recovery and decreased memory capacity in children with a history of DKA.
Authors: Nicole Glaser; Steven Chu; Justin Weiner; Linnea Zdepski; Heike Wulff; Daniel Tancredi; Martha E ODonnell Journal: BMJ Open Diabetes Res Care Date: 2022-05
Authors: Simona Ghetti; Nathan Kuppermann; Arleta Rewers; Sage R Myers; Jeff E Schunk; Michael J Stoner; Aris Garro; Kimberly S Quayle; Kathleen M Brown; Jennifer L Trainor; Leah Tzimenatos; Andrew D DePiero; Julie K McManemy; Lise E Nigrovic; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; Nicole S Glaser Journal: Diabetes Care Date: 2020-09-22 Impact factor: 19.112
Authors: Sage R Myers; Nicole S Glaser; Jennifer L Trainor; Lise E Nigrovic; Aris Garro; Leah Tzimenatos; Kimberly S Quayle; Maria Y Kwok; Arleta Rewers; Michael J Stoner; Jeff E Schunk; Julie K McManemy; Kathleen M Brown; Andrew D DePiero; Cody S Olsen; T Charles Casper; Simona Ghetti; Nathan Kuppermann Journal: JAMA Netw Open Date: 2020-12-01
Authors: Nicole Glaser; Steven Chu; Benjamin Hung; Luis Fernandez; Heike Wulff; Daniel Tancredi; Martha E ODonnell Journal: BMJ Open Diabetes Res Care Date: 2020-12
Authors: Allan L Reiss; Booil Jo; Ana Maria Arbelaez; Eva Tsalikian; Bruce Buckingham; Stuart A Weinzimer; Larry A Fox; Allison Cato; Neil H White; Michael Tansey; Tandy Aye; William Tamborlane; Kimberly Englert; John Lum; Paul Mazaika; Lara Foland-Ross; Matthew Marzelli; Nelly Mauras Journal: Nat Commun Date: 2022-08-30 Impact factor: 17.694